A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...

Gilead Sciences (GILD) announced on Thursday that its Phase 3 ARTISTRY-1 trial, which tested its new single-tablet regimen of ...

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

The trial evaluated treatment responses in patients who were virologically suppressed while switching from a multi-tablet ...

The ARTISTRY-1 Phase III trial demonstrated that a single-tablet regimen of bictegravir 75 mg/lenacapavir 50 mg maintains viral suppression and simplifies therapy for people living with HIV, ...

In people with HIV infection aged 60 years or older, the long-acting cabotegravir and rilpivirine combination maintains high ...

Despite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human ...

Magic Johnson recalls the difficult conversation he had with his wife, Cookie Johnson, about his HIV diagnosis.

Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at ...

An alleged rapist deliberately infected seven young men with HIV, a court has been told. Adam Hall, from Donwell in ...